Table 2.
Evaluation of the procedures
| Authors | Retention rate (%) | Complication rate (%) | Visual acuity BCVA of ≥20/200 |
|---|---|---|---|
| Goins et al.(14) | 85.3 (64/75) | Retroprosthetic membrane Maculopathy - 34.7 | Final: 57.3 (43/75) |
| Aravena et al.(15) | 74.3 (55/74) | Retroprosthetic membrane - 51.7 | Mean: 86 (50/58) Final: 22 (18/50) |
| Muzychuk et al.(16) | 24 months: (37/37 60 months: 96 (25/26) |
Glaucoma - 65 Retroprosthetic membrane - 47 |
2 years: 57 (21/37) Final: 46 (12/26) |
| Rudnisky et al.(17) | 93 (279/300) | NI | Mean: 84.7 (254/300) Final: 80.9 (241/300) |
| Ang et al.(18) | 90 (59/66) | NI | 3,5 years: 100 (66/66) 5-year estimative: 60 (40/66) |
| Driver et al.(19) | 90 (207/231) | Retroprosthetic membrane - 40 e
51 Persistent epithelial defect - 37 e 24 |
1 year:
69.05 (145/210) Final: 41.07 (23/56) |
| Lee et al.(20) | 50 (24/48) | Retroprosthetic membrane - 60.4 | Mean: 91.7 (44/48) Final: 37.5 (18/48) |
| Basu et al.(21) | Boston type I KPro: 70.5
(55/78) Aurolab KPro: 62.5 (35/56) |
Glaucoma - 28.4 | Boston type I, mean: 87.3
(68/78) Final: 26.92 (21/78) Aurolab KPro, mean: 90 (49/56) Final: 26.78 (15/56) |
| Venugopal et al.(22) | 73.3 (11/15) | Retroprosthetic membrane -
46.7 Graft infection - 26.7 |
Final: 60 (9/15) |
| Charoenrook et al.(23) | OOKP: 67 (97/145) Tibial bone keratoprothesis: (61/113) | Retinal detachment - 15 e
16 Retroprosthetic membrane - 3 e 23 |
NI |
| Duignan et al.(24) | Boston type I KPro: 85
(29/34) Boston type II KPro: 67 (2/3) |
Retroprosthetic membrane -
52.9 Glaucoma - 17.6 |
Final: 82.4 (28/34) |
BCVA= best-corrected visual acuity; NI= not indicated; OOKP= osteo-odonto-keratoprosthesis.